Schedule 13G ownership disclosure

MIRAGEN THERAPEUTICS, INC.

Security class unavailable · CUSIP: 60463E202

Event date: 2020-10-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
550,000
Percent of class
14.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-20-000614
Form type
SC 13G/A
Filer
Logos Global Management LP
CIK
CIK 1792126
Filed
Nov 16, 2020
Reporting period
Oct 28, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub